Michelle Peter has more than 18 years of experience in the Pharmaceutical, Biotechnology, and Medical Device industries. Her career has focused on Quality Assurance and Clinical Operations spanning across sponsor companies, contract research organizations, and clinical sites. She has led the execution of corporate quality assurance initiatives including developing and improving inspection readiness programs, Quality Management System implementations, Trial Master File (TMF) strategy and management, audits, remediation of compliance gaps, and risk identification and mitigation.
Before joining Halloran, Michelle was a Manager, Clinical Quality Assurance at La Jolla Pharmaceutical Company (LJPC) where she was responsible for managing cross-functional teams to ensure GCP compliance for clinical development programs. Before joining LJPC, Michelle held a series of positions across multiple therapeutic areas at companies including Tocagen, Inc., Cato Research, and Harvard Clinical Research Institute.
Michelle earned a Master of Advanced Studies in Clinical Research from the University of California San Diego and a Bachelor of Science in Communication from Boston University College of Communication. She received her Certificate in Clinical Research from the Boston University Graduate School of Medical Sciences.